Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 27 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2021 Filed Mar 25, 2021 20:05 UTC |
NIXON D. GAILSenior VP, Human Resources
|
GrantPerformance Rights · Derivative | 7,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013466 · doc4.xml · derivative · entry 2 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,197 Underlying: Common Stock · 7,197 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2021 and ending December 31, 2023. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2021 and ending December 31, 2023. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:05 UTC |
NIXON D. GAILSenior VP, Human Resources
|
GrantCommon Stock | 8,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-013466 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,228 F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 23, 2022. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC |
BUCHAN JOHNSee Remarks
|
Tax withholdingCommon Stock | 1,708 | $7.82 | $13,356.56 |
DisclosureSEC source: 0000899243-21-011929 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,910 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
Tax withholdingCommon Stock | 1,348 | $7.82 | $10,541.36 |
DisclosureSEC source: 0000899243-21-011925 · doc4.xml · nonDerivative · entry 1 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,274 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC |
Veltman Warren ADirector · President and CEO
|
Tax withholdingCommon Stock | 1,621 | $7.82 | $12,676.22 |
DisclosureSEC source: 0000899243-21-011927 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,166 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 20:05 UTC |
NIXON D. GAILSenior VP, Human Resources
|
Tax withholdingCommon Stock | 913 | $7.82 | $7,139.66 |
DisclosureSEC source: 0000899243-21-011921 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,502 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:11 UTC |
NIXON D. GAILSenior VP, Human Resources
|
Tax withholdingCommon Stock | 5,450 | $6.81 | $37,114.50 |
DisclosureSEC source: 0000899243-21-007590 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,415 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:09 UTC |
Veltman Warren ADirector · President and CEO
|
Tax withholdingCommon Stock | 6,029 | $6.81 | $41,057.49 |
DisclosureSEC source: 0000899243-21-007588 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,787 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:06 UTC |
BUCHAN JOHNSee Remarks
|
Tax withholdingCommon Stock | 14,842 | $6.81 | $101,074.02 |
DisclosureSEC source: 0000899243-21-007586 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,618 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:02 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
Tax withholdingCommon Stock | 11,754 | $6.81 | $80,044.74 |
DisclosureSEC source: 0000899243-21-007583 · doc4.xml · nonDerivative · entry 1 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,622 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:57 UTC |
DeByle Thomas D.Senior Vice President and CFO
|
Tax withholdingCommon Stock | 1,136 | $6.81 | $7,736.16 |
DisclosureSEC source: 0000899243-21-007581 · doc4.xml · nonDerivative · entry 1 DeByle Thomas D. · CIK 0001429686 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,069 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:22 UTC |
Brunner Robert EDirector
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000468 · doc4.xml · nonDerivative · entry 1 Brunner Robert E · CIK 0001380372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,803 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:21 UTC |
Wilson Thomas Hampton Jr.Director
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000466 · doc4.xml · nonDerivative · entry 1 Wilson Thomas Hampton Jr. · CIK 0001539343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,120 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:19 UTC |
WARSHAW STEVEN TDirector
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000463 · doc4.xml · nonDerivative · entry 1 WARSHAW STEVEN T · CIK 0001196823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,535 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:17 UTC |
BENVENUTI RAYNARD D.Director
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000459 · doc4.xml · nonDerivative · entry 1 BENVENUTI RAYNARD D. · CIK 0001801647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,790 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:16 UTC |
HARMAN JERI JDirector
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000457 · doc4.xml · nonDerivative · entry 1 HARMAN JERI J · CIK 0001168314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,830 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:11 UTC |
Carroll ChristinaDirector
|
GrantCommon Stock | 24,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-000450 · doc4.xml · nonDerivative · entry 1 Carroll Christina · CIK 0001731636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,120 F1 · kind: Shares are restricted stock and vest on January 4, 2022. Read SEC document |
| October 07, 2020 Filed Oct 13, 2020 20:05 UTC |
DeByle Thomas D.Senior Vice President and CFO
|
Tax withholdingCommon Stock | 9,001 | $6.30 | $56,706.30 |
DisclosureSEC source: 0000899243-20-027997 · doc4.xml · nonDerivative · entry 1 DeByle Thomas D. · CIK 0001429686 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,205 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| September 20, 2020 Filed Oct 13, 2020 20:05 UTC |
Veltman Warren APresident and CEO
|
Tax withholdingCommon Stock | 8,046 | $5.69 | $45,781.74 |
DisclosureSEC source: 0000899243-20-027999 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,816 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Reflects an increase by one share due to rounding in the withholding calculation in the Reporting Person's previous Form 4 report. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:06 UTC |
Veltman Warren APresident and CEO
|
Tax withholdingCommon Stock | 374 | $2.89 | $1,080.86 |
DisclosureSEC source: 0000899243-20-008999 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,861 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:05 UTC |
NIXON D. GAILSenior VP, Human Resources
|
Tax withholdingCommon Stock | 210 | $2.89 | $606.90 |
DisclosureSEC source: 0000899243-20-008997 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,865 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:05 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
Tax withholdingCommon Stock | 381 | $2.89 | $1,101.09 |
DisclosureSEC source: 0000899243-20-008995 · doc4.xml · nonDerivative · entry 1 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,376 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:05 UTC |
Qualters Christopher J.Executive VP of Life Sciences
|
Tax withholdingCommon Stock | 326 | $2.89 | $942.14 |
DisclosureSEC source: 0000899243-20-008992 · doc4.xml · nonDerivative · entry 1 Qualters Christopher J. · CIK 0001707268 · Executive VP of Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,457 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 14, 2020 Filed Mar 18, 2020 00:00 UTC |
NIXON D. GAILSenior VP, Human Resources
|
Tax withholdingCommon Stock | 1,106 | $4.01 | $4,435.06 |
DisclosureSEC source: 0000899243-20-008711 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,075 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Reflects a decrease by one share due to rounding in the withholding calculation in previous Form 4 report. Read SEC document |
| March 14, 2020 Filed Mar 18, 2020 00:04 UTC |
Veltman Warren APresident and CEO
|
Tax withholdingCommon Stock | 1,581 | $4.01 | $6,339.81 |
DisclosureSEC source: 0000899243-20-008715 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,235 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Reflects a decrease by one share due to rounding in the withholding calculation in previous Form 4 report. Read SEC document |
| March 14, 2020 Filed Mar 17, 2020 23:57 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
Tax withholdingCommon Stock | 1,641 | $4.01 | $6,580.41 |
DisclosureSEC source: 0000899243-20-008709 · doc4.xml · nonDerivative · entry 1 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,757 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · balance_after: Reflects a decrease by one share due to rounding in the withholding calculation in previous Form 4 report. Read SEC document |
| March 14, 2020 Filed Mar 17, 2020 23:55 UTC |
Qualters Christopher J.Executive VP of Life Sciences
|
Tax withholdingCommon Stock | 1,631 | $4.01 | $6,540.31 |
DisclosureSEC source: 0000899243-20-008707 · doc4.xml · nonDerivative · entry 1 Qualters Christopher J. · CIK 0001707268 · Executive VP of Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,783 F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:22 UTC |
DeByle Thomas D.Senior Vice President and CFO
|
GrantPerformance Rights · Derivative | 27,261 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005298 · doc4.xml · derivative · entry 2 DeByle Thomas D. · CIK 0001429686 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,261 Underlying: Common Stock · 27,261 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:22 UTC |
DeByle Thomas D.Senior Vice President and CFO
|
GrantCommon Stock | 9,728 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005298 · doc4.xml · nonDerivative · entry 1 DeByle Thomas D. · CIK 0001429686 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,206 F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
Qualters Christopher J.Executive VP of Life Sciences
|
GrantPerformance Rights · Derivative | 11,988 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005294 · doc4.xml · derivative · entry 2 Qualters Christopher J. · CIK 0001707268 · Executive VP of Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,988 Underlying: Common Stock · 11,988 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
Qualters Christopher J.Executive VP of Life Sciences
|
GrantCommon Stock | 54,377 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005294 · doc4.xml · nonDerivative · entry 1 Qualters Christopher J. · CIK 0001707268 · Executive VP of Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,414 F1 · kind: Shares are restricted stock with 13,590 shares vesting in three equal annual installments beginning on February 18, 2021 with the remaining 40,783 shares vesting in full on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
BUCHAN JOHNSee Remarks
|
GrantPerformance Rights · Derivative | 13,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005293 · doc4.xml · derivative · entry 2 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,233 Underlying: Common Stock · 13,233 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
BUCHAN JOHNSee Remarks
|
GrantCommon Stock | 60,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005293 · doc4.xml · nonDerivative · entry 1 BUCHAN JOHN · CIK 0001789436 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,460 F1 · kind: Shares are restricted stock with 15,007 shares vesting in three equal annual installments beginning on February 18, 2021 with the remaining 45,021 shares vesting in full on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
GrantPerformance Rights · Derivative | 12,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005292 · doc4.xml · derivative · entry 2 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,143 Underlying: Common Stock · 12,143 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:19 UTC |
Heiter Matthew S.Senior VP and General Counsel
|
GrantCommon Stock | 55,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005292 · doc4.xml · nonDerivative · entry 1 Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,399 F1 · kind: Shares are restricted stock with 13,771 shares vesting in three equal annual installments beginning on February 18, 2021 with the remaining 41,313 shares vesting in full on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:17 UTC |
NIXON D. GAILSenior VP, Human Resources
|
GrantPerformance Rights · Derivative | 5,768 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005289 · doc4.xml · derivative · entry 2 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,768 Underlying: Common Stock · 5,768 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:17 UTC |
NIXON D. GAILSenior VP, Human Resources
|
GrantCommon Stock | 20,126 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005289 · doc4.xml · nonDerivative · entry 1 NIXON D. GAIL · CIK 0001713507 · Senior VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,182 F1 · kind: Shares are restricted stock with 6,541 shares vesting in three equal annual installments beginning on February 18, 2021 with the remaining 13,585 shares vesting in full on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:17 UTC |
Veltman Warren APresident and CEO
|
GrantPerformance Rights · Derivative | 53,596 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005288 · doc4.xml · derivative · entry 2 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,596 Underlying: Common Stock · 53,596 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer"). F3 · derivative.exercise_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. F3 · derivative.expiration_date: The performance rights will vest pursuant to the terms and subject to the conditions set forth in the Issuer's 2019 Omnibus Incentive Plan and the applicable Performance Share Unit Award Agreement based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2020 and ending December 31, 2022. The performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:17 UTC |
Veltman Warren APresident and CEO
|
GrantCommon Stock | 60,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005288 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,817 F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on February 18, 2021. Read SEC document |
| January 31, 2020 Filed Feb 3, 2020 21:12 UTC |
BENVENUTI RAYNARD D.Director
|
GrantCommon Stock | 15,956 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002540 · doc4.xml · nonDerivative · entry 1 BENVENUTI RAYNARD D. · CIK 0001801647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,956 F1 · kind: Shares are restricted stock and vest on January 31, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:07 UTC |
Floyd DavidDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000506 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,946 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:11 UTC |
PUGH DAVID LDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000510 · doc4.xml · nonDerivative · entry 1 PUGH DAVID L · CIK 0001208344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,801 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC |
HARMAN JERI JDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000504 · doc4.xml · nonDerivative · entry 1 HARMAN JERI J · CIK 0001168314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,996 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:05 UTC |
Brunner Robert EDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000499 · doc4.xml · nonDerivative · entry 1 Brunner Robert E · CIK 0001380372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,969 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC |
WARSHAW STEVEN TDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000505 · doc4.xml · nonDerivative · entry 1 WARSHAW STEVEN T · CIK 0001196823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,701 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:05 UTC |
Wilson Thomas Hampton Jr.Director
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000500 · doc4.xml · nonDerivative · entry 1 Wilson Thomas Hampton Jr. · CIK 0001539343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,286 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:06 UTC |
Carroll ChristinaDirector
|
GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000502 · doc4.xml · nonDerivative · entry 1 Carroll Christina · CIK 0001731636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,286 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 20:05 UTC |
DeByle Thomas D.Senior Vice President and CFO
|
GrantCommon Stock | 30,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-025298 · doc4.xml · nonDerivative · entry 1 DeByle Thomas D. · CIK 0001429686 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,478 F1 · kind: Shares are restricted stock and vest in full on October 7, 2020. Read SEC document |
| September 20, 2019 Filed Sep 24, 2019 11:30 UTC |
Veltman Warren APresident and CEO
|
GrantCommon Stock | 28,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-024116 · doc4.xml · nonDerivative · entry 1 Veltman Warren A · CIK 0001618759 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,039 F1 · kind: Shares are restricted stock and vest in full on September 20, 2020. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:05 UTC |
Atkinson James RobertEVP, Life Sciences
|
PurchaseCommon Stock | 3,000 | $8.65 | $25,950.00 |
DisclosureSEC source: 0000899243-19-017789 · doc4.xml · nonDerivative · entry 1 Atkinson James Robert · CIK 0001674150 · EVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,550 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.